Welcome to this week’s Pharma Roundup. In this episode, we begin with a peri operative immunotherapy that lowers gastric cancer relapse, move to an FDA decision that lets a prostate cancer pill skip chemotherapy prerequisites, continue with a wearable injector that trims myeloma treatment to five minutes, and finish with the agency’s choice to drop extra safety hurdles so more hospitals can deliver lifesaving CAR T therapy. Together these stories underscore faster surgeries, wider oral options, time saving devices, and streamlined regulation that could bring cutting edge care closer to patients everywhere.